Q3 2022 Oncopeptides AB Earnings Call Transcript
Good day, and welcome to the Oncopeptides Third Quarter 2022 Earnings Call. (Operator Instructions) Please note that this event is being recorded. I would now like to turn the conference over to Jakob Lindberg, CEO. Please go ahead.
()-
Thank you. Warm welcome to the third quarter 2022 webcast for Oncopeptides. My name is Jakob Lindberg. Before we start, let's jump to Slide #2. Here, you can see today's speakers, it's myself, with also Sofia Heigis, Chief Commercial Officer; and Annika Muskantor, Chief Financial Officer.
On Slide #3, you will see the regular disclaimers. There's nothing special in here. If you want to read this carefully. It is available also on our website.
On Slide #4, you see an overview of today's presentation, where I will give a general update regarding the company as well as the clinical and regulatory update. Sofia Heigis will give a commercial update given our ongoing launch in Europe, especially the German market.
Annika Muskantor will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
